This is a routine commercial leadership change with no new financial guidance or strategic update. Monitor the next quarterly report for any changes in commercial execution or revenue trajectory under the new EVP of Commercial.
Price Chart
Executive Summary
Myriad Genetics announced the departure of Chief Commercial Officer Brian Donnelly (effective Sept 16, 2026, with a transition period through Sept 21) and the internal promotion of Vishal Sikri from SVP of Product to EVP of Commercial. The company also reaffirmed its full-year 2026 financial guidance as previously announced on July 30, 2026. This is a routine leadership change with no new financial data or strategic pivot, and the guidance reaffirmation provides no incremental information for traders.
Key Facts
- Chief Commercial Officer Brian Donnelly departed effective September 16, 2026, and will remain as a non-executive employee through September 21, 2026 for transition.
- Vishal Sikri was promoted from SVP of Product to EVP of Commercial, effective September 16, 2026.
- The company reaffirmed its full-year 2026 financial guidance, as announced during the Q2 2026 earnings call on July 30, 2026.
- No financial figures, guidance details, or quantitative data were disclosed in this filing.
Financial Impact
No financial impact disclosed; guidance reaffirmation provides no new quantitative data.
Risk Factors
- Commercial execution risk during leadership transition period (Donnelly departs Sept 21, Sikri steps in immediately).
- No incremental financial data provided — guidance reaffirmation offers no new information for valuation.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000899923-26-000079 |
| Exhibit: ex991pressreleasedatedsept.htm | 0000899923-26-000079 |
| Document: 0000899923-26-000079-index-headers.html | 0000899923-26-000079 |
| Document: 0000899923-26-000079-index.html | 0000899923-26-000079 |
| Document: 0000899923-26-000079.txt | 0000899923-26-000079 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $3.86 $4.01 | ▲ +3.89% | ▲ +1.32% | $4.54 (+17.62%) |
Sep 16, 2026 16d ago | Press Release | $3.86 $4.01 | ▲ +3.89% | ▲ +1.32% | $4.54 (+17.62%) |
Aug 4, 2026 8w ago | Press Release | $3.17 $3.22 | ▼ −1.58% | ▼ −1.68% | $4.54 (−43.22%) |
Jul 30, 2026 9w ago | Press Release | $2.86 $3.26 | ▼ −13.99% | ▼ −10.47% | $4.54 (−58.74%) |
May 27, 2026 18w ago | Press Release | $3.93 $4.31 | ▲ +9.67% | ▲ +8.46% | $4.54 (+15.52%) |
Mar 17, 2026 28w ago | Press Release | $4.64 $4.68 | ▲ +0.86% | ▲ +1.58% | $4.54 (−2.16%) |
Feb 28, 2026 30w ago | Institutional Cluster | $5.01 $4.81 | ▼ −3.99% | ▼ −2.78% | $4.54 (−9.38%) |
Feb 24, 2026 31w ago | S-3 | $4.78 $5.28 | ▲ +10.46% | ▲ +11.56% | $4.54 (−5.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access